Cargando…

Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides

BACKGROUND: During the inflammation which occurs following nerve damage, macrophages are recruited to the site of injury. Phenotypic diversity is a hallmark of the macrophage lineage and includes pro-inflammatory M1 and anti-inflammatory M2 populations. Our aim in this study was to investigate the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pannell, Maria, Labuz, Dominika, Celik, Melih Ö., Keye, Jacqueline, Batra, Arvind, Siegmund, Britta, Machelska, Halina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055715/
https://www.ncbi.nlm.nih.gov/pubmed/27717401
http://dx.doi.org/10.1186/s12974-016-0735-z
_version_ 1782458802036015104
author Pannell, Maria
Labuz, Dominika
Celik, Melih Ö.
Keye, Jacqueline
Batra, Arvind
Siegmund, Britta
Machelska, Halina
author_facet Pannell, Maria
Labuz, Dominika
Celik, Melih Ö.
Keye, Jacqueline
Batra, Arvind
Siegmund, Britta
Machelska, Halina
author_sort Pannell, Maria
collection PubMed
description BACKGROUND: During the inflammation which occurs following nerve damage, macrophages are recruited to the site of injury. Phenotypic diversity is a hallmark of the macrophage lineage and includes pro-inflammatory M1 and anti-inflammatory M2 populations. Our aim in this study was to investigate the ability of polarized M0, M1, and M2 macrophages to secrete opioid peptides and to examine their relative contribution to the modulation of neuropathic pain. METHODS: Mouse bone marrow-derived cells were cultured as unstimulated M0 macrophages or were stimulated into an M1 phenotype using lipopolysaccharide and interferon-γ or into an M2 phenotype using interleukin-4. The macrophage phenotypes were verified using flow cytometry for surface marker analysis and cytokine bead array for cytokine profile assessment. Opioid peptide levels were measured by radioimmunoassay and enzyme immunoassay. As a model of neuropathic pain, a chronic constriction injury (CCI) of the sciatic nerve was employed. Polarized M0, M1, and M2 macrophages (5 × 10(5) cells) were injected perineurally twice, on days 14 and 15 following CCI or sham surgery. Mechanical and heat sensitivity were measured using the von Frey and Hargreaves tests, respectively. To track the injected macrophages, we also transferred fluorescently stained polarized cells and analyzed the surface marker profile of endogenous and injected cells in the nerves ex vivo. RESULTS: Compared to M0 and M1 cells, M2 macrophages contained and released higher amounts of opioid peptides, including Met-enkephalin, dynorphin A (1–17), and β-endorphin. M2 cells transferred perineurally at the nerve injury site reduced mechanical, but not heat hypersensitivity following the second injection. The analgesic effect was reversed by the perineurally applied opioid receptor antagonist naloxone methiodide. M2 cells did not affect sensitivity following sham surgery. Neither M0 nor M1 cells altered mechanical and heat sensitivity in CCI or sham-operated animals. Tracing the fluorescently labeled M0, M1, and M2 cells ex vivo showed that they remained in the nerve and preserved their phenotype. CONCLUSIONS: Perineural transplantation of M2 macrophages resulted in opioid-mediated amelioration of neuropathy-induced mechanical hypersensitivity, while M1 macrophages did not exacerbate pain. Therefore, rather than focusing on macrophage-induced pain generation, promoting opioid-mediated M2 actions may be more relevant for pain control.
format Online
Article
Text
id pubmed-5055715
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50557152016-10-19 Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides Pannell, Maria Labuz, Dominika Celik, Melih Ö. Keye, Jacqueline Batra, Arvind Siegmund, Britta Machelska, Halina J Neuroinflammation Research BACKGROUND: During the inflammation which occurs following nerve damage, macrophages are recruited to the site of injury. Phenotypic diversity is a hallmark of the macrophage lineage and includes pro-inflammatory M1 and anti-inflammatory M2 populations. Our aim in this study was to investigate the ability of polarized M0, M1, and M2 macrophages to secrete opioid peptides and to examine their relative contribution to the modulation of neuropathic pain. METHODS: Mouse bone marrow-derived cells were cultured as unstimulated M0 macrophages or were stimulated into an M1 phenotype using lipopolysaccharide and interferon-γ or into an M2 phenotype using interleukin-4. The macrophage phenotypes were verified using flow cytometry for surface marker analysis and cytokine bead array for cytokine profile assessment. Opioid peptide levels were measured by radioimmunoassay and enzyme immunoassay. As a model of neuropathic pain, a chronic constriction injury (CCI) of the sciatic nerve was employed. Polarized M0, M1, and M2 macrophages (5 × 10(5) cells) were injected perineurally twice, on days 14 and 15 following CCI or sham surgery. Mechanical and heat sensitivity were measured using the von Frey and Hargreaves tests, respectively. To track the injected macrophages, we also transferred fluorescently stained polarized cells and analyzed the surface marker profile of endogenous and injected cells in the nerves ex vivo. RESULTS: Compared to M0 and M1 cells, M2 macrophages contained and released higher amounts of opioid peptides, including Met-enkephalin, dynorphin A (1–17), and β-endorphin. M2 cells transferred perineurally at the nerve injury site reduced mechanical, but not heat hypersensitivity following the second injection. The analgesic effect was reversed by the perineurally applied opioid receptor antagonist naloxone methiodide. M2 cells did not affect sensitivity following sham surgery. Neither M0 nor M1 cells altered mechanical and heat sensitivity in CCI or sham-operated animals. Tracing the fluorescently labeled M0, M1, and M2 cells ex vivo showed that they remained in the nerve and preserved their phenotype. CONCLUSIONS: Perineural transplantation of M2 macrophages resulted in opioid-mediated amelioration of neuropathy-induced mechanical hypersensitivity, while M1 macrophages did not exacerbate pain. Therefore, rather than focusing on macrophage-induced pain generation, promoting opioid-mediated M2 actions may be more relevant for pain control. BioMed Central 2016-10-07 /pmc/articles/PMC5055715/ /pubmed/27717401 http://dx.doi.org/10.1186/s12974-016-0735-z Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Pannell, Maria
Labuz, Dominika
Celik, Melih Ö.
Keye, Jacqueline
Batra, Arvind
Siegmund, Britta
Machelska, Halina
Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides
title Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides
title_full Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides
title_fullStr Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides
title_full_unstemmed Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides
title_short Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides
title_sort adoptive transfer of m2 macrophages reduces neuropathic pain via opioid peptides
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055715/
https://www.ncbi.nlm.nih.gov/pubmed/27717401
http://dx.doi.org/10.1186/s12974-016-0735-z
work_keys_str_mv AT pannellmaria adoptivetransferofm2macrophagesreducesneuropathicpainviaopioidpeptides
AT labuzdominika adoptivetransferofm2macrophagesreducesneuropathicpainviaopioidpeptides
AT celikmeliho adoptivetransferofm2macrophagesreducesneuropathicpainviaopioidpeptides
AT keyejacqueline adoptivetransferofm2macrophagesreducesneuropathicpainviaopioidpeptides
AT batraarvind adoptivetransferofm2macrophagesreducesneuropathicpainviaopioidpeptides
AT siegmundbritta adoptivetransferofm2macrophagesreducesneuropathicpainviaopioidpeptides
AT machelskahalina adoptivetransferofm2macrophagesreducesneuropathicpainviaopioidpeptides